OPA1 and lung carcinoma: Wang et al. reported that ANXA2 may stimulate AKT activation, promote tumor growth and metastasis and interact with TIM-4 to regulate oxidative phosphorylation in lung cancer cells via the ANXA2/PI3K/AKT/OPA1 pathway to accelerate tumor progression [36].